AB HiResolution Bionic Ear System, HiRes Ultra CI, MS Electrode - Product Usage: The device is in...
FDA Device Recall #Z-2033-2020 — Class II — February 17, 2020
Recall Summary
| Recall Number | Z-2033-2020 |
| Classification | Class II — Moderate risk |
| Date Initiated | February 17, 2020 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Advanced Bionics, LLC |
| Location | Valencia, CA |
| Product Type | Devices |
| Quantity | 14068 units (CI-1600-04 = 9772 units and CI-1600-05 = 4296 units) |
Product Description
AB HiResolution Bionic Ear System, HiRes Ultra CI, MS Electrode - Product Usage: The device is intended to restore a level of auditory sensation to patients with profound sensorineural deafness via electrical stimulation of the auditory nerve.
Reason for Recall
hearing performance degradation due to body-fluid entering the device.
Distribution Pattern
Worldwide distribution - US Nationwide distribution and the countries of Canada, Brazil, Bangladesh, Switzerland, China, Australia, India, South Korea, Thailand, Ecuador, Mexico, El Salvador, Guatemala, Malaysia, Myanmar, Taiwan, Chile, Costa Rica, Colombia, Panama, Japan, Argentina, Peru, Singapore, China, New Zealand, Vietnam, Dominican Republic Refer to uploaded consignee lists in Associated Documents: Exhibit 05_ConsigneeList_Center_17FEB2020 Exhibit 06_ConsigneeList_Professionals_17FEB2020 Exhibit 07_ConsigneeList_Patients_17RFEB2020
Lot / Code Information
Model Numbers: CI 1600 04 - HiRes Ultra with HF Mid-Scala Electrode CI 1600 05 - HiRes Ultra with HF Mid-Scala Electrode Lot Numbers - 1000000 thru 1999999.
Other Recalls from Advanced Bionics, LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1493-2026 | Class II | Brand Name: HiResolution Bionic Ear System Pro... | Nov 27, 2025 |
| Z-1813-2025 | Class II | HiResolution" Bionic Ear System - M Battery Cha... | Mar 5, 2025 |
| Z-0487-2021 | Class III | AB PowerCel 170 (velvet black), REF: CI-5517-15... | Sep 26, 2020 |
| Z-0486-2021 | Class III | AB PowerCel 230 (velvet black), REF: CI-5523-15... | Sep 26, 2020 |
| Z-2032-2020 | Class II | AB HiResolution Bionic Ear System, HiRes Ultra ... | Feb 17, 2020 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.